• Tue news: Pfizer explores sale of hospital drugs unit. FDA declines full approval of Ocaliva. AZ better than expected Q3 results. Pfizer, Lilly telehealth platforms draw scrutiny. 23andMe cutting lays off 40%. See more on our front page

Eisai adopts Medidata’s AI-driven platform for clinical trials

cafead

Administrator
Staff member
  • cafead   Jul 26, 2024 at 11:32: AM
via Eisai has adopted Medidata’s Clinical Data Studio, which aims to transform and modernising the clinical trial efficiency and patient experience.

article source